BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34994484)

  • 1. Risk factors associated with short-term mortality and recurrence of status epilepticus in dogs.
    Fentem R; de Stefani A; Quintana RG; Alcoverro E; Jones GMC; Amengual-Batle P; Gonçalves R
    J Vet Intern Med; 2022 Mar; 36(2):656-662. PubMed ID: 34994484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996).
    Saito M; Muñana KR; Sharp NJ; Olby NJ
    J Am Vet Med Assoc; 2001 Sep; 219(5):618-23. PubMed ID: 11549089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Risk Factors for Early Seizure Recurrence in Dogs Hospitalized for Seizure Evaluation.
    Kwiatkowska M; Tipold A; Huenerfauth E; Pomianowski A
    J Vet Intern Med; 2018 Mar; 32(2):757-763. PubMed ID: 29457273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis.
    Blades Golubovic S; Rossmeisl JH
    J Vet Emerg Crit Care (San Antonio); 2017 May; 27(3):288-300. PubMed ID: 28445601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
    Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
    J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine idiopathic epilepsy: prevalence, risk factors and outcome associated with cluster seizures and status epilepticus.
    Monteiro R; Adams V; Keys D; Platt SR
    J Small Anim Pract; 2012 Sep; 53(9):526-30. PubMed ID: 22835069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.
    Charalambous M; Bhatti SFM; Van Ham L; Platt S; Jeffery ND; Tipold A; Siedenburg J; Volk HA; Hasegawa D; Gallucci A; Gandini G; Musteata M; Ives E; Vanhaesebrouck AE
    J Vet Intern Med; 2017 Jul; 31(4):1149-1158. PubMed ID: 28543780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995).
    Bateman SW; Parent JM
    J Am Vet Med Assoc; 1999 Nov; 215(10):1463-8. PubMed ID: 10579043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures.
    Cagnotti G; Odore R; Bertone I; Corona C; Dappiano E; Gardini G; Iulini B; Bellino C; D'Angelo A
    J Vet Intern Med; 2019 Jul; 33(4):1714-1718. PubMed ID: 31218767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status epilepticus and cluster seizures.
    Patterson EN
    Vet Clin North Am Small Anim Pract; 2014 Nov; 44(6):1103-12. PubMed ID: 25245182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol versus sodium thiopentone for the treatment of status epilepticus and refractory status epilepticus in dogs.
    Espiñeira I; Alzate D; Araos J; Pellegrino F; Tunesi M; Jensen M; Donati PA
    N Z Vet J; 2023 May; 71(3):128-132. PubMed ID: 36688794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
    Cagnotti G; Odore R; Gardini G; Amedeo S; Bertone I; Guerriero G; Lentini L; Dappiano E; D'Angelo A
    BMC Vet Res; 2018 Jun; 14(1):189. PubMed ID: 29914474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status epilepticus and epileptic seizures in dogs.
    Zimmermann R; Hülsmeyer V-; Sauter-Louis C; Fischer A
    J Vet Intern Med; 2009; 23(5):970-6. PubMed ID: 19737178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine status epilepticus treated with fosphenytoin: A proof of principle study.
    Patterson EE; Leppik IE; Coles LD; Podell M; Vite CH; Bush W; Cloyd JC
    Epilepsia; 2015 Jun; 56(6):882-7. PubMed ID: 25953073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of long-term unprovoked seizures after status epilepticus.
    Rodrigo-Gisbert M; Gómez-Dabó L; Quintana M; Campos-Fernández D; Lallana S; Fonseca E; Abraira L; Toledo M; Santamarina E
    Epilepsia; 2023 Sep; 64(9):2399-2408. PubMed ID: 37347842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining and overcoming the therapeutic obstacles in canine refractory status epilepticus.
    Charalambous M; Bhatti SFM; Volk HA; Platt S
    Vet J; 2022; 283-284():105828. PubMed ID: 35429630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous rate infusion of midazolam as emergent treatment for seizures in dogs.
    Bray KY; Mariani CL; Early PJ; Muñana KR; Olby NJ
    J Vet Intern Med; 2021 Jan; 35(1):388-396. PubMed ID: 33325618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine status epilepticus: a retrospective study of 50 cases.
    Platt SR; Haag M
    J Small Anim Pract; 2002 Apr; 43(4):151-3. PubMed ID: 11996390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus.
    Pan Y; Feng Y; Peng W; Cai Y; Ding J; Wang X
    BMC Neurol; 2022 Sep; 22(1):348. PubMed ID: 36104657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.